Skip to product information
1 of 1

SMAD3 (phospho S423+S425) Recombinant Rabbit mAb (S-541-321)

SMAD3 (phospho S423+S425) Recombinant Rabbit mAb (S-541-321)

Catalog Number: S0B0948 Application: WB,IP Reactivity: Human,Mouse,Rat Conjugation: Unconjugated Brand: Starter
Price:
Regular price $130.00 SGD
Regular price Sale price $130.00 SGD
Size:
For shipping services or bulk orders, you may request a quotation.
Secure checkout with
View full details

Product Details

Product Specification


Host Rabbit
Antigen SMAD3 (phospho S423+S425)
Synonyms Mothers against decapentaplegic homolog 3; MAD homolog 3; Mad3; Mothers against DPP homolog 3; hMAD-3; JV15-2; SMAD family member 3; MADH3
Immunogen Synthetic Peptide
Location Nucleus
Accession P84022
Clone Number S-541-321
Antibody Type Recombinant mAb
Isotype IgG
Application WB, IP
Reactivity Hu, Ms, Rt
Predicted Reactivity Ms
Purification Protein A
Concentration 0.5 mg/ml
Conjugation Unconjugated
Physical Appearance Liquid
Storage Buffer

PBS, 40% Glycerol, 0.05% BSA, 0.03% Proclin 300

Stability & Storage

12 months from date of receipt / reconstitution, -20 °C as supplied

Dilution


application dilution species
WB 1:1000
IP 1:50

Background

SMAD3 is a protein intracellular signal transducer that is part of the TGF-β (transforming growth factor-beta) superfamily signaling pathway. When SMAD3 is phosphorylated at serine residues 423 and 425 (referred to as SMAD3 (phospho S423+S425)), it indicates activation of the TGF-β signaling cascade within a cell. This phosphorylation event typically occurs after SMAD3 binds to the activated TGF-β receptor, leading to its phosphorylation and subsequent interaction with SMAD4. Together, they accumulate in the nucleus where they regulate gene expression associated with various cellular processes, including cell growth, differentiation, and immune responses. In the context of disease research, understanding SMAD3 phosphorylation is particularly relevant in conditions such as cancer, where dysregulation of TGF-β signaling can contribute to tumor progression and metastasis. SMAD3 is also implicated in fibrotic diseases, cardiovascular diseases, and immune responses, making it a potential therapeutic target for these conditions.

Picture

Western Blot

WB result of SMAD3 (phospho S423 + S425) Recombinant Rabbit mAb
Primary antibody: SMAD3 (phospho S423 + S425) Recombinant Rabbit mAb at 1/1000 dilution
Lane 1: untreated HT-1080 whole cell lysate 20 µg
Lane 2: HT-1080 treated with 10 ng/ml TGF-β for 30 minutes whole cell lysate 20 µg
Secondary antibody: Goat Anti-rabbit IgG, (H+L), HRP conjugated at 1/10000 dilution
Predicted MW: 48 kDa
Observed MW: 55 kDa

WB result of SMAD3 (phospho S423 + S425) Recombinant Rabbit mAb
Primary antibody: SMAD3 (phospho S423 + S425) Recombinant Rabbit mAb at 1/1000 dilution
Lane 1: untreated C2C12 whole cell lysate 20 µg
Lane 2: C2C12 treated with 10 ng/ml TGF-β for 30 minutes whole cell lysate 20 µg
Secondary antibody: Goat Anti-rabbit IgG, (H+L), HRP conjugated at 1/10000 dilution
Predicted MW: 48 kDa
Observed MW: 55 kDa

WB result of SMAD3 (phospho S423 + S425) Recombinant Rabbit mAb
Primary antibody: SMAD3 (phospho S423 + S425) Recombinant Rabbit mAb at 1/1000 dilution
Lane 1: untreated C6 whole cell lysate 20 µg
Lane 2: C6 treated with 10 ng/ml TGF-β for 30 minutes whole cell lysate 20 µg
Secondary antibody: Goat Anti-rabbit IgG, (H+L), HRP conjugated at 1/10000 dilution
Predicted MW: 48 kDa
Observed MW: 55 kDa

IP

Smad3 (phospho S423 + S425) Recombinant Rabbit mAb at 1/50 dilution (1 µg) immunoprecipitating Smad3 (phospho S423 + S425) in 0.4 mg HT-1080+TGF-β(10 ng/ml, 30 min) whole cell lysate.
Western blot was performed on the immunoprecipitate using Smad3 (phospho S423 + S425) Recombinant Rabbit mAb at 1/1000 dilution.
Secondary antibody (HRP) for IP was used at 1/1000 dilution.
Lane 1: HT-1080+TGF-β(10 ng/ml, 30 min) whole cell lysate 20 µg (Input)
Lane 2: Smad3 (phospho S423 + S425) Recombinant Rabbit mAb IP in HT-1080+TGF-β(10 ng/ml, 30 min) whole cell lysate
Lane 3: Rabbit monoclonal IgG IP in HT-1080+TGF-β(10 ng/ml, 30 min) whole cell lysate
Predicted MW: 48 kDa
Observed MW: 55 kDa
Exposure time: 20 s

Customer Reviews

Be the first to write a review
0%
(0)
0%
(0)
0%
(0)
0%
(0)
0%
(0)